Ali Akbar Velayati

InstitutionShahid beheshti university of medical sciences
AddressTehran
Iran
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 14 Covid-19 publications, with a maximum of 7 publications in December 2020
    All Publications
    Bar chart showing 160 publications over 21 distinct years, with a maximum of 23 publications in 2016
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Hashemian SM, Khoundabi B, Velayati AA. Comment on: Safety and efficacy of Favipiravir in moderate to severe SARS-CoV-2 pneumonia. Int Immunopharmacol. 2022 01; 102:107693. PMID: 34217670.
      Citations:    Fields:    Translation:Humans
    2. Rezaei M, Sadeghi M, Korourian A, Tabarsi P, Porabdollah M, Askari E, Mortaz E, Mahmoudi S, Marjani M, Velayati AA. Comparative evaluation of SARS-CoV-2 IgG assays against nucleocapsid and spike antigens. Hum Antibodies. 2021; 29(2):109-113. PMID: 33720878.
      Citations:    Fields:    Translation:HumansCells
    3. Hashemian SM, Farhadi T, Velayati AA. A review on favipiravir: the properties, function, and usefulness to treat COVID-19. Expert Rev Anti Infect Ther. 2021 08; 19(8):1029-1037. PMID: 33372567.
      Citations: 4     Fields:    Translation:Humans
    4. Baghaei P, Dastan F, Marjani M, Moniri A, Abtahian Z, Ghadimi S, Valizadeh M, Heshmatnia J, Sadat Mirenayat M, Abedini A, Kiani A, Eslaminejad A, MohammadReza Hashemian S, Jamaati H, Zali A, Akbar Velayati A, Tabarsi P. Combination therapy of IFNß1 with lopinavir-ritonavir, increases oxygenation, survival and discharging of sever COVID-19 infected inpatients. Int Immunopharmacol. 2021 Mar; 92:107329. PMID: 33412395.
      Citations: 9     Fields:    Translation:Humans
    5. Sofian M, Velayati AA, Banifazl M, Fotouhi F, Sadat Larijani M, Afzali N, Ramezani A. SARS-CoV-2, a virus with many faces: a series of cases with prolonged persistence of COVID-19 symptoms. Wien Med Wochenschr. 2021 Feb; 171(1-2):3-6. PMID: 33315163.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    6. Dezfuli NK, Adcock IM, Montazami N, Mortaz E, Velayati A. Update on Immunology of COVID-19 Disease and Potential Strategy for Controlling. Tanaffos. 2020 Dec; 19(4):274-290. PMID: 33959165.
      Citations: 2     
    7. Hashemian SM, Shafigh N, Afzal G, Jamaati H, Mortaz E, Tabarsi P, Marjani M, Malekmohammad M, Dastan F, Mortazavi SM, Sadr M, Idani E, Khoundabi B, Mohamadnia A, Abedini A, Kiani A, Moniri A, Nadji SA, Yassari F, Mokhber Dezfuli M, Pourabdollah M, Varahram M, Eshaghi F, Malekpour M, Velayati A. Blood Purification Techniques, Inflammatory Mediators and Mortality in COVID-19 Patients. Tanaffos. 2020 Dec; 19(4):291-299. PMID: 33959166.
      Citations: 1     
    8. Vahedi A, Tabasi F, Monjazebi F, Hashemian SMR, Tabarsi P, Farzanegan B, Malekmohammad M, Salimi A, Salimi M, Raoufy MR, Jamaati H, Velayati AA. Clinical Features and Outcomes of ICU Patients with COVID-19 Infection in Tehran, Iran: a Single-Centered Retrospective Cohort Study. Tanaffos. 2020 Dec; 19(4):300-311. PMID: 33959167.
      Citations: 2     
    9. Babamahmoodi A, Moniri A, Sadr M, Poorhosseini SM, Rezaei M, Marjani M, Velayati AA. Trisomy 21 as a Risk Factor for Severe Illness in COVID-19: Report of two Cases. Tanaffos. 2020 Dec; 19(4):413-417. PMID: 33959180.
      Citations:    
    10. Citations: 2     
    11. Najafi A, Ghanei M, Janbabaei G, Velayati AA, Saadat SH, Jamaati H, Tabarsi P, Dastan F, Ram M, Darabi E, Fathi S, Gholami Fesharaki M, Ghazale AH, Saloo S. Real Clinical Practice and Therapeutic Management Following COVID-19 Crisis in two Hospitals in Iran: A Statistical and Conceptual View. Tanaffos. 2020 Nov; 19(2):112-121. PMID: 33262798.
      Citations:    
    12. Baghaei P, Nadji SA, Marjani M, Moniri A, Hashemian SM, Sheikhzade H, Abtahian Z, Heshmatnia J, Abedini A, Jamaati H, Mansourafshar B, Ahmadi ZH, Mokhber Dezfuli M, Seifi S, Sadeghi M, Mirenayat MS, Yassari F, Lookzadeh S, Farzanegan B, Kiani A, Vasheghani M, Dastan F, Eslaminejad A, Malekmohammad M, Varahram M, Zali A, Tabarsi P, Velayati AA. Clinical Manifestations of Patients with Coronavirus Disease 2019 (COVID-19) in a Referral Center in Iran. Tanaffos. 2020 Nov; 19(2):122-128. PMID: 33262799.
      Citations:    
    13. Pourabdollah Toutkaboni M, Askari E, Askari E, Khalili N, Tabarsi P, Jamaati H, Jamaati H, Velayati AA, Dorudinia A, Rezaei M, Nadji SA, Mohamadnia A, Khalili N. Demographics, laboratory parameters and outcomes of 1061 patients with coronavirus disease 2019: a report from Tehran, Iran. New Microbes New Infect. 2020 Nov; 38:100777. PMID: 33042553.
      Citations: 2     
    14. Hashemian SM, Farhadi T, Velayati AA. A Review on Remdesivir: A Possible Promising Agent for the Treatment of COVID-19. Drug Des Devel Ther. 2020; 14:3215-3222. PMID: 32821086.
      Citations: 13     Fields:    Translation:HumansAnimalsPHPublic Health
    Velayati's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (155)
    Explore
    _
    Co-Authors (94)
    Explore
    _
    Similar People (60)
    Explore
    _